GE HealthCare Technologies (MEX:GEHC) Tariff Resilience Score: 7/10 (As of Jul. 04, 2026)


MEX:GEHC GE HealthCare Technologies Inc MEX:GEHC
63 GF Score
Price MXN1,149.89
GF Value MXN1,493.20
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is GE HealthCare Technologies Tariff Resilience Score?

GE HealthCare Technologies MEX:GEHC 63 Tariff Resilience Score is 7 as of Jul. 04, 2026. GuruFocus rates MEX:GEHC with a GF Score™ of 63/100 and a GF Value™ of MXN1,493.20 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 837 Medical Devices & Instruments companies, GE HealthCare Technologies ranks better than 98.09% on this metric.

GE HealthCare Technologies has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

GE HealthCare Technologies has Strong global presence with diversified manufacturing and sales markets. Healthcare equipment often benefits from tariff exemptions. Historical adaptability to tariff changes and strong pricing power enhance resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes GE HealthCare Technologies might have Highly Resilient.

GE HealthCare Technologies  (MEX:GEHC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

GE HealthCare Technologies Tariff Resilience Score Related Terms

MEX:GEHC vs DXCM, STE, ZBH: Tariff Resilience Score Comparison

For the Medical Devices subindustry, GE HealthCare Technologies's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GE HealthCare Technologies Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's Tariff Resilience Score falls into.


MEX:GEHC
63GF Score
GE HealthCare Technologies Inc MEX:GEHC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
GE HealthCare Technologies (MEX:GEHC) has a Tariff Resilience Score of 7 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, GE HealthCare Technologies ranks #16 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is GE HealthCare Technologies' Tariff Resilience Score too high?
GE HealthCare Technologies' current Tariff Resilience Score is 7. Based on the distribution chart, GE HealthCare Technologies ranks #16 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, GE HealthCare Technologies has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Tariff Resilience Score compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #16 out of 837 companies for Tariff Resilience Score. This places GE HealthCare Technologies in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. GE HealthCare Technologies's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MEX:GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,493.20, compared to a current price of MXN1,149.89 — trading 23% below its estimated fair value. The current Tariff Resilience Score is 7. GE HealthCare Technologies' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For GE HealthCare Technologies (MEX:GEHC), the current Tariff Resilience Score is 7 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GE HealthCare Technologies (MEX:GEHC) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of MXN1,149.89 is trading 23% below its estimated GF Value™ of MXN1,493.20. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for MEX:GEHC:

  • Tariff Resilience Score: 7
  • GF Value™: MXN1,493.20 vs. price of MXN1,149.89 (23% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the MEX:GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
63GF Score

Get the complete analysis for MEX:GEHC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,149.89
Price
MXN1,493.20
GF Value